Fienmixperijoo No. 2

Adult dosage

For nitrogen: 0.16 g/kg body weight per day (1 g/kg body weight per day for amino acids) to 0.35 g/kg body weight per day (2 g/kg body weight per day for amino acids) via intravenous drip. The maximum infusion rate is 3 mL/kg body weight per hour, and for adults weighing 60-70 kg, it is 180-210 mL per hour. The maximum daily dosage is 40 mL/kg body weight.

Children's dosage

For nitrogen: 0.35 g/kg body weight per day (2 g/kg body weight per day for amino acids) to 0.45 g/kg body weight per day (3 g/kg body weight per day for amino acids) via intravenous drip.

This medication must be used strictly according to a physician's instructions. When using other medications containing calcium intravenously, it must not be mixed with Ceftriaxone and should not be administered using the same infusion device simultaneously. It should not be administered to specific patient groups such as neonates, patients with severe liver disease, history of myocardial infarction, or patients with severe renal impairment. During administration, the patient's condition must be closely monitored, and if any abnormal symptoms appear, administration must be stopped immediately. If administered peripherally, there may be vein irritation, so the administration route and osmolality should be carefully determined. Blood glucose, electrolyte levels, and kidney and liver function tests should be conducted regularly to check for abnormalities. This medication may affect bodily fluid balance and circulating blood volume, so caution is needed in patients such as those with heart failure. The safety has not been established for pregnant and lactating women, and it should only be administered when the benefits outweigh the risks. In case of overdose, symptoms such as acidosis, fluid overload, and hyperglycemia may appear, and if these symptoms occur, administration should be stopped immediately and specialized treatment sought if necessary. Do not use if the solution is not clear or if the container is damaged, and after mixing, it should be used only once and any remaining medication should be discarded. When mixing with other medications, the compatibility must be confirmed and mixed in a sterile condition, and administration should occur as soon as possible after mixing.

Mild side effects

• Nausea
• vomiting
• chills
• hyperglycemia
• diabetes
• osmotic symptoms
• acidosis
• increased blood sugar
• electrolyte concentration abnormalities
• potential for blood coagulability.

This medication should be stored in a sealed container to protect it from air and light exposure, and it is advisable to keep it in a cool place below 25 degrees Celsius.

Appearance

A colorless to pale yellow transparent liquid in a colorless transparent plastic container, which is separated internally by a partition.

Package unit

500 mL/bag, 1000 mL/bag